Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study to Assess the Safety and Exploratory Immunogenicity of PV-001

NCT07081334 is registered in ClinicalTrials.gov with POSVAX as lead sponsor.

NCT NCT07081334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07081334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study to Assess the Safety and Exploratory Immunogenicity of PV-001
Lead sponsor
POSVAX
Phase
Phase 1
Overall status
Completed
Start date
August 17, 2022
Completion date
January 30, 2025
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infections